CoChat
Sign Up
Cited by 71

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Polycomb group proteins in the DNA damage response: A link between radiation resistance and “stemness”

Gieni, Randall S., Ismail, Ismail H., Campbell, Stuart, Hendzel, Michael J.·2011·Cell Cycle
DOI 10.4161/cc.10.6.14907
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/cc.10.6.14907

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 10 references

Research works printed but not linked: 88

  1. Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silenc- ing. Mol Cell 2005; 20:845-54.
  2. de Napoles M, Mermoud J, Wakao R, Tang Y, Endoh M, Appanah R, et al. Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev Cell 2004; 7:663-76.
  3. Ismail IH, Andrin C, McDonald D, Hendzel MJ. BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J Cell Biol 2010; 191:45-60.
  4. Wei J, Zhai L, Xu J, Wang H. Role of Bmi1 in H2A ubiquitylation and Hox gene silencing. J Biol Chem 2006; 281:22537-44.
  5. Bernstein KA, Rothstein R. At loose ends: resecting a double-strand break. Cell 2009; 137:807-10.
  6. Helleday T. Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis 2010; 31:955-60.
  7. Jeggo P, Lavin MF. Cellular radiosensitivity: how much better do we understand it? Int J Radiat Biol 2009; 85:1061-81.
  8. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-join- ing pathway. Annu Rev Biochem 2010; 79:181-211.
  9. Hartlerode AJ, Scully R. Mechanisms of double- strand break repair in somatic mammalian cells. Biochem J 2009; 423:157-68.
  10. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461:1071-8.
  11. Kass EM, Jasin M. Collaboration and competition between DNA double-strand break repair pathways. FEBS Lett 2010; 584:3703-8.
  12. Lisby M, Rothstein R. Choreography of recombina- tion proteins during the DNA damage response. DNA Repair (Amst) 2009; 8:1068-76.
  13. Jeggo PA, Lobrich M. DNA double-strand breaks: their cellular and clinical impact? Oncogene 2007; 26:7717-9.
  14. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73:39-85.
  15. Larson GP, Zhang G, Ding S, Foldenauer K, Udar N, Gatti RA, et al. An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genet Test 1997; 1:165-70.
  16. Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, et al. Contributions of ATM muta- tions to familial breast and ovarian cancer. Cancer Res 2003; 63:3325-33.
  17. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, et al. Hereditary breast cancer: patho- biology, prognosis and BRCA1 and BRCA2 gene linkage. Cancer 1996; 77:697-709.
  18. Roukos DH. Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 2007; 357:1555-6.
  19. Nikkila J, Coleman KA, Morrissey D, Pylkas K, Erkko H, Messick TE, et al. Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response func- tion. Oncogene 2009; 28:1843-52.
  20. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 2010; 10:293-301.
  21. Bolderson E, Richard DJ, Zhou BB, Khanna KK. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 2009; 15:6314-20.
  22. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, et al. Specific killing of BRCA2- deficient tumours with inhibitors of poly(ADP- ribose) polymerase. Nature 2005; 434:913-7.
  23. Turner N, Tutt A, Ashworth A. Targeting the DNA repair defect of BRCA tumours. Curr Opin Pharmacol 2005; 5:388-93. References
  24. Gieni RS, Hendzel MJ. Polycomb group protein gene silencing, non-coding RNA, stem cells and cancer. Biochem Cell Biol 2009; 87:711-46.
  25. Negishi M, Saraya A, Miyagi S, Nagao K, Inagaki Y, Nishikawa M, et al. Bmi1 cooperates with Dnmt1- associated protein 1 in gene silencing. Biochem Biophys Res Commun 2007; 353:992-8.
  26. Reynolds P, Sigaroudinia M, Zardo G, Wilson M, Benton G, Miller C, et al. Tumor suppressor p16 INK4A regulates polycomb-mediated DNA hypermethyl- ation in human mammary epithelial cells. J Biol Chem 2006; 281:24790-802.
  27. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439:871-4.
  28. Glinsky GV. "Stemness" genomics law governs clini- cal behavior of human cancer: implications for deci- sion making in disease management. J Clin Oncol 2008; 26:2846-53.
  29. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008; 27:7274-84.
  30. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group pro- teins. Annu Rev Genet 2004; 38:413-43.
  31. Jacobs JJ, van Lohuizen M. Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta 2002; 1602:151-61.
  32. Saurin AJ, Shao Z, Erdjument-Bromage H, Tempst P, Kingston RE. A Drosophila Polycomb group complex includes Zeste and dTAFII proteins. Nature 2001; 412:655-60.
  33. Li Z, Cao R, Wang M, Myers M, Zhang Y, Xu R. Structure of a Bmi-1-Ring1B polycomb group ubiqui- tin ligase complex. J Biol Chem 2006; 281:20643-9.
  34. Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, Jones R, et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004; 431:873-8.
  35. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1, a mediator of the DNA damage checkpoint. Science 2002; 298:1435-8.
  36. Difilippantonio S, Gapud E, Wong N, Huang CY, Mahowald G, Chen HT, et al. 53BP1 facilitates long- range DNA end-joining during V(D)J recombina- tion. Nature 2008; 456:529-33.
  37. Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10:550-63.
  38. Nakada S, Tai I, Panier S, Al-Hakim A, Iemura S, Juang YC, et al. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature 2010; 466:941-6.
  39. Chen X, Arciero CA, Wang C, Broccoli D, Godwin AK. BRCC36 is essential for ionizing radiation- induced BRCA1 phosphorylation and nuclear foci formation. Cancer Res 2006; 66:5039-46.
  40. Nicassio F, Corrado N, Vissers JH, Areces LB, Bergink S, Marteijn JA, et al. Human USP3 is a chromatin modifier required for S phase progression and genome stability. Curr Biol 2007; 17:1972-7.
  41. Sobhian B, Shao G, Lilli DR, Culhane AC, Moreau LA, Xia B, et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 2007; 316:1198-202.
  42. Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, et al. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell 2003; 12:1087-99.
  43. Shao G, Lilli DR, Patterson-Fortin J, Coleman KA, Morrissey DE, Greenberg RA. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc Natl Acad Sci USA 2009; 106:3166-71.
  44. Joo HY, Zhai L, Yang C, Nie S, Erdjument-Bromage H, Tempst P, et al. Regulation of cell cycle progres- sion and gene expression by H2A deubiquitination. Nature 2007; 449:1068-72.
  45. Cai SY, Babbitt RW, Marchesi VT. A mutant deubiq- uitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. Proc Natl Acad Sci USA 1999; 96:2828-33.
  46. Maertens GN, El Messaoudi-Aubert S, Elderkin S, Hiom K, Peters G. Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J 2010; 29:2553-65.
  47. Scheuermann JC, de Ayala Alonso AG, Oktaba K, Ly-Hartig N, McGinty RK, Fraterman S, et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 2010; 465:243-7.
  48. Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiq- uitinating activity and nuclear localization. Cancer Res 2008; 68:6953-62.
  49. Chen YC, Chang CJ, Hsu HS, Chen YW, Tai LK, Tseng LM, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 2010; 46:158-65.
  50. Alajez NM, Shi W, Hui AB, Yue S, Ng R, Lo KW, et al. Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy. Cell Death Differ 2009; 16:1469-79.
  51. Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007; 67:8980-4.
  52. Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, et al. DNA damage, homology- directed repair and DNA methylation. PLoS Genet 2007; 3:110.
  53. Alchanati I, Teicher C, Cohen G, Shemesh V, Barr HM, Nakache P, et al. The E3 ubiquitin-ligase Bmi1/ Ring1A controls the proteasomal degradation of Top2alpha cleavage complex-a potentially new drug target. PLoS One 2009; 4:8104.
  54. Hansen KH, Bracken AP, Pasini D, Dietrich N, Gehani SS, Monrad A, et al. A model for transmis- sion of the H3K27me3 epigenetic mark. Nat Cell Biol 2008; 10:1291-300.
  55. Xu C, Bian C, Yang W, Galka M, Ouyang H, Chen C, et al. Binding of different histone marks dif- ferentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2). Proc Natl Acad Sci USA 2010; 107:19266-71.
  56. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 2008; 4:1000242.
  57. Jorgensen HF, Giadrossi S, Casanova M, Endoh M, Koseki H, Brockdorff N, et al. Stem cells primed for action: polycomb repressive complexes restrain the expression of lineage-specific regulators in embryonic stem cells. Cell Cycle 2006; 5:1411-4.
  58. Kallin EM, Cao R, Jothi R, Xia K, Cui K, Zhao K, et al. Genome-wide uH2A localization analysis highlights Bmi1-dependent deposition of the mark at repressed genes. PLoS Genet 2009; 5:1000506.
  59. Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R, et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromo- somes to allow accumulation of repair proteins. Cell 2009; 136:435-46.
  60. Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 2007; 131:887-900.
  61. Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 2007; 131:901-14.
  62. Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD, et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 2007; 318:1637-40.
  63. Huen MS, Huang J, Yuan J, Yamamoto M, Akira S, Ashley C, et al. Noncanonical E2 variant-indepen- dent function of UBC13 in promoting checkpoint protein assembly. Mol Cell Biol 2008; 28:6104-12.
  64. Wu J, Huen MS, Lu LY, Ye L, Dou Y, Ljungman M, et al. Histone ubiquitination associates with BRCA1- dependent DNA damage response. Mol Cell Biol 2009; 29:849-60.
  65. Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 2009; 136:420- 34.
  66. Sato Y, Yoshikawa A, Mimura H, Yamashita M, Yamagata A, Fukai S. Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by tandem UIMs of RAP80. EMBO J 2009; 28:2461-8.
  67. Stewart GS. Solving the RIDDLE of 53BP1 recruit- ment to sites of damage. Cell Cycle 2009; 8:1532-8.
  68. Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J, et al. Structural basis for the meth- ylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 2006; 127:1361-73.
  69. Fong PC, Yap TA, Boss DS, Carden CP, Mergui- Roelvink M, Gourley C, et al. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J Clin Oncol 2010; 28:2512-9.
  70. Facchino S, Abdouh M, Chatoo W, Bernier G. BMI1 confers radioresistance to normal and cancer- ous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci 2010; 30:10096-111.
  71. Hong Z, Jiang J, Lan L, Nakajima S, Kanno S, Koseki H, et al. A polycomb group protein, PHF1, is involved in the response to DNA double-strand breaks in human cell. Nucleic Acids Res 2008; 36:2939-47.
  72. Haince JF, McDonald D, Rodrigue A, Dery U, Masson JY, Hendzel MJ, et al. PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J Biol Chem 2008; 283:1197-208.
  73. El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res 2003; 31:5526-33.
  74. Huber A, Bai P, de Murcia JM, de Murcia G. PARP- 1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development. DNA Repair (Amst) 2004; 3:1103-8.
  75. Krishnakumar R, Kraus WL. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 2010; 39:736-49.
  76. Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes and clinical targets. Mol Cell 2010; 39:8-24.
  77. Elderkin S, Maertens GN, Endoh M, Mallery DL, Morrice N, Koseki H, et al. A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin. Mol Cell 2007; 28:107-20.
  78. Margueron R, Li G, Sarma K, Blais A, Zavadil J, Woodcock CL, et al. Ezh1 and Ezh2 maintain repres- sive chromatin through different mechanisms. Mol Cell 2008; 32:503-18.
  79. Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X, et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 2008; 32:491-502.
  80. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncod- ing RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38:662-74.
  81. Senthilkumar R, Mishra RK. Novel motifs distin- guish multiple homologues of Polycomb in verte- brates: expansion and diversification of the epigenetic toolkit. BMC Genomics 2009; 10:549.
  82. Wu X, Gong Y, Yue J, Qiang B, Yuan J, Peng X. Cooperation between EZH2, NSPc1-mediated his- tone H2A ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res 2008; 36:3590-9.
  83. Gong Y, Yue J, Wu X, Wang X, Wen J, Lu L, et al. NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21 Waf1/Cip1 via the RARE element. Nucleic Acids Res 2006; 34:6158-69.
  84. Puppe J, Drost R, Liu X, Joosse SA, Evers B, Cornelissen-Steijger P, et al. BRCA1-deficient mam- mary tumor cells are dependent on EZH2 expres- sion and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A. Breast Cancer Res 2009; 11:63. 100. Chalmers AJ. Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors. Anticancer Agents Med Chem 2010; 10:520-33.
  85. Ohm JE, Baylin SB. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 2007; 6:1040-3.
  86. Lee GE, Kim JH, Taylor M, Muller MT. DNA Methyltransferase 1-associated Protein (DMAP1) Is a Co-repressor That Stimulates DNA Methylation Globally and Locally at Sites of Double Strand Break Repair. J Biol Chem 2010; 285:37630-40.
  87. Calvanese V, Horrillo A, Hmadcha A, Suarez-Alvarez B, Fernandez AF, Lara E, et al. Cancer genes hyper- methylated in human embryonic stem cells. PLoS One 2008; 3:3294.
  88. Dellaire G, Kepkay R, Bazett-Jones DP. High resolu- tion imaging of changes in the structure and spa- tial organization of chromatin, gamma-H2A.X and the MRN complex within etoposide-induced DNA repair foci. Cell Cycle 2009; 8:3750-69.

Cited by

Sorted by citations

See all 71

Metadata

Authors
Gieni, R. S., Ismail, I. H., Campbell, S., & Hendzel, M. J.
Venue
Cell Cycle
Publisher
Informa UK Limited
Published
2011-03-15
Volume
10
Issue
6
Pages
883-894
ISSN
  • 1538-4101
  • 1551-4005
DOI
10.4161/cc.10.6.14907
Cited by
71
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review